Nadine Schwarz: How Genetic Variation Shapes Protein C Pathway Function
Nadine Schwarz, Research Associate at Institute of Experimental Hematology and Transfusion Medicine in University Hospital Bonn, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Blood Advances, adding:
“Excited to share our latest publication in Blood Advances!
We investigated how common genetic variants in THBD and PROCR influence the anticoagulant response of the protein C pathway using both in vivo and ex vivo experimental models.
By combining controlled coagulation activation in human participants with endothelial cell-based functional assays, we were able to dissect the distinct effects of these variants on protein C pathway function.
I am grateful to all my colleagues and co-authors who contributed to this study.”
Title: In vivo and ex vivo impact of THBD and PROCR polymorphisms on the anticoagulant response of the protein C pathway
Authors: Sara Reda, Nadine Schwarz, Sebastian Eckert, Jens Müller, Johannes Oldenburg, Bernd Pötzsch, Behnaz Pezeshkpoor, Heiko Rühl
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 29, 2026, 12:37Dan Milikovsky: Uncovering Cerebrovascular Injury in Sickle Cell Disease
-
Sep 29, 2026, 12:02Hajra Malik: Bridging Language Gaps in Hematology With AI
-
Sep 29, 2026, 11:57Joan Montaner: Can Blood Test Identify Intracerebral Hemorrhage Within Minutes?
-
Sep 29, 2026, 11:43From Years Without Answers to Life With Hemophilia Care – WFH
-
Sep 29, 2026, 11:32Sara Al Dallal: Transforming Hemophilia Care Across the Gulf
-
Sep 29, 2026, 11:21Richard Davis: Rapid Rescue in Massive Pulmonary Embolism
-
Sep 29, 2026, 11:14Nissan Brown: Every Step Counts for the Hemophilia Community
-
Sep 29, 2026, 11:03Zain Khalpey: SINGLE AF Adds New Evidence to the Anticoagulation Debate
-
Sep 29, 2026, 10:54How Does Haemophilia Affect Motor Development in Infants? – EAHAD